Literature DB >> 24067382

IL-6 regulates neutrophil microabscess formation in IL-17A-driven psoriasiform lesions.

Andrew L Croxford1, Susanne Karbach2, Florian C Kurschus3, Simone Wörtge3, Alexei Nikolaev3, Nir Yogev3, Sabrina Klebow3, Rebecca Schüler3, Sonja Reissig3, Carolin Piotrowski4, Elke Brylla4, Ingo Bechmann4, Jürgen Scheller5, Stefan Rose-John6, F Thomas Wunderlich7, Thomas Münzel8, Esther von Stebut5, Ari Waisman9.   

Abstract

The lack of a generally accepted animal model for human psoriasis has hindered progress with respect to understanding the pathogenesis of the disease. Here we present a model in which transgenic IL-17A expression is targeted to the skin in mice, achievable after crossing our IL-17A(ind) allele to the K14-Cre strain. K14-IL-17A(ind/+) mice invariably develop an overt skin inflammation bearing many hallmark characteristics of human psoriasis including dermal infiltration of effector T cells, formation of neutrophil microabscesses, and hyperkeratosis. IL-17A expression in the skin results in upregulated granulopoiesis and migration of IL-6R-expressing neutrophils into the skin. Neutralization of IL-6 signaling efficiently reduces the observed pathogenesis in skin of IL-17A-overexpressing mice, with marked reductions in epidermal neutrophil abscess formation and epidermal thickening. Thus, IL-6 functions downstream of IL-17A to exacerbate neutrophil microabscess development in psoriasiform lesions.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 24067382     DOI: 10.1038/jid.2013.404

Source DB:  PubMed          Journal:  J Invest Dermatol        ISSN: 0022-202X            Impact factor:   8.551


  57 in total

Review 1.  IL-6 signaling in autoimmunity, chronic inflammation and inflammation-associated cancer.

Authors:  Markus F Neurath; Susetta Finotto
Journal:  Cytokine Growth Factor Rev       Date:  2011-03-05       Impact factor: 7.638

2.  Stat3 links activated keratinocytes and immunocytes required for development of psoriasis in a novel transgenic mouse model.

Authors:  Shigetoshi Sano; Keith Syson Chan; Steve Carbajal; John Clifford; Mary Peavey; Kaoru Kiguchi; Satoshi Itami; Brian J Nickoloff; John DiGiovanni
Journal:  Nat Med       Date:  2004-12-12       Impact factor: 53.440

3.  IL-17 is essential for host defense against cutaneous Staphylococcus aureus infection in mice.

Authors:  John S Cho; Eric M Pietras; Nairy C Garcia; Romela Irene Ramos; David M Farzam; Holly R Monroe; Julie E Magorien; Andrew Blauvelt; Jay K Kolls; Ambrose L Cheung; Genhong Cheng; Robert L Modlin; Lloyd S Miller
Journal:  J Clin Invest       Date:  2010-04-01       Impact factor: 14.808

4.  Interleukin-17 is produced by both Th1 and Th2 lymphocytes, and modulates interferon-gamma- and interleukin-4-induced activation of human keratinocytes.

Authors:  C Albanesi; C Scarponi; A Cavani; M Federici; F Nasorri; G Girolomoni
Journal:  J Invest Dermatol       Date:  2000-07       Impact factor: 8.551

5.  Critical role of the interleukin-17/interleukin-17 receptor axis in regulating host susceptibility to respiratory infection with Chlamydia species.

Authors:  Xiaohui Zhou; Qiangwei Chen; Jessica Moore; Jay K Kolls; Scott Halperin; Jun Wang
Journal:  Infect Immun       Date:  2009-09-08       Impact factor: 3.441

6.  The roles of CCR6 in migration of Th17 cells and regulation of effector T-cell balance in the gut.

Authors:  C Wang; S G Kang; J Lee; Z Sun; C H Kim
Journal:  Mucosal Immunol       Date:  2009-01-07       Impact factor: 7.313

7.  Interplay between IFN-gamma and IL-6 signaling governs neutrophil trafficking and apoptosis during acute inflammation.

Authors:  Rachel M McLoughlin; Janusz Witowski; Rachel L Robson; Thomas S Wilkinson; Suzanne M Hurst; Anwen S Williams; John D Williams; Stefan Rose-John; Simon A Jones; Nicholas Topley
Journal:  J Clin Invest       Date:  2003-08       Impact factor: 14.808

8.  MIP-1alpha and MIP-1beta differentially mediate mucosal and systemic adaptive immunity.

Authors:  James W Lillard; Udai P Singh; Prosper N Boyaka; Shailesh Singh; Dennis D Taub; Jerry R McGhee
Journal:  Blood       Date:  2002-09-12       Impact factor: 22.113

Review 9.  Mouse models of psoriasis.

Authors:  Johann E Gudjonsson; Andrew Johnston; Melissa Dyson; Helgi Valdimarsson; James T Elder
Journal:  J Invest Dermatol       Date:  2007-04-12       Impact factor: 8.551

10.  An alternative pathway of imiquimod-induced psoriasis-like skin inflammation in the absence of interleukin-17 receptor a signaling.

Authors:  Khalifa El Malki; Susanne H Karbach; Jula Huppert; Morad Zayoud; Sonja Reissig; Rebecca Schüler; Alexej Nikolaev; Khalad Karram; Thomas Münzel; Christoph R W Kuhlmann; Heiko J Luhmann; Esther von Stebut; Simone Wörtge; Florian C Kurschus; Ari Waisman
Journal:  J Invest Dermatol       Date:  2012-09-06       Impact factor: 8.551

View more
  41 in total

1.  Expression of IL-17F is associated with non-pathogenic Th17 cells.

Authors:  Florian Wanke; Yilang Tang; Konrad Gronke; Sabrina Klebow; Sonja Moos; Judith Hauptmann; Arthi Shanmugavadivu; Tommy Regen; Ilgiz A Mufazalov; Lauren A Gabriel; Sonja Reißig; Andreas Diefenbach; Florian C Kurschus; Ari Waisman
Journal:  J Mol Med (Berl)       Date:  2018-06-29       Impact factor: 4.599

2.  Cutting edge: NF-κB p65 and c-Rel control epidermal development and immune homeostasis in the skin.

Authors:  Yenkel Grinberg-Bleyer; Teruki Dainichi; Hyunju Oh; Nicole Heise; Ulf Klein; Roland M Schmid; Matthew S Hayden; Sankar Ghosh
Journal:  J Immunol       Date:  2015-02-13       Impact factor: 5.422

Review 3.  [New insights into the function of bone marrow].

Authors:  G Schett; A Bozec; I Bekeredjian-Ding; H-D Chang; J-P David; T Dörner; S Grässel; M Gunzer; R Manz; H Mei; D Mielenz; U Müller-Ladner; E Neumann; A Radbruch; W Richter; R H Straub
Journal:  Z Rheumatol       Date:  2018-05       Impact factor: 1.372

4.  T Cell-Independent Mechanisms Associated with Neutrophil Extracellular Trap Formation and Selective Autophagy in IL-17A-Mediated Epidermal Hyperplasia.

Authors:  Erika Suzuki; Emanual Maverakis; Ritu Sarin; Laura Bouchareychas; Vijay K Kuchroo; Frank O Nestle; Iannis E Adamopoulos
Journal:  J Immunol       Date:  2016-10-24       Impact factor: 5.422

Review 5.  Immune responses and therapeutic options in psoriasis.

Authors:  Inna S Afonina; Elien Van Nuffel; Rudi Beyaert
Journal:  Cell Mol Life Sci       Date:  2021-01-02       Impact factor: 9.261

Review 6.  Repositioning TH cell polarization from single cytokines to complex help.

Authors:  Selma Tuzlak; Florent Ginhoux; Thomas Korn; Burkhard Becher; Anne S Dejean; Matteo Iannacone; Francisco J Quintana; Ari Waisman
Journal:  Nat Immunol       Date:  2021-09-20       Impact factor: 25.606

Review 7.  IL-17 in neonatal health and disease.

Authors:  Shelley M Lawrence; Jessica Lauren Ruoss; James L Wynn
Journal:  Am J Reprod Immunol       Date:  2017-12-15       Impact factor: 3.886

8.  Calcium/calmodulin-dependent protein kinase IV signaling pathway is upregulated in experimental necrotizing enterocolitis.

Authors:  Mashriq Alganabi; Haitao Zhu; Joshua S O'Connell; George Biouss; Andrea Zito; Bo Li; Edoardo Bindi; Agostino Pierro
Journal:  Pediatr Surg Int       Date:  2020-01-16       Impact factor: 1.827

9.  E3 ubiquitin ligase NEDD4L negatively regulates keratinocyte hyperplasia by promoting GP130 degradation.

Authors:  Huan Liu; Wenlong Lin; Zhiyong Liu; Yinjing Song; Hao Cheng; Huazhang An; Xiaojian Wang
Journal:  EMBO Rep       Date:  2021-03-26       Impact factor: 8.807

Review 10.  New Frontiers in Psoriatic Disease Research, Part I: Genetics, Environmental Triggers, Immunology, Pathophysiology, and Precision Medicine.

Authors:  Di Yan; Johann E Gudjonsson; Stephanie Le; Emanual Maverakis; Olesya Plazyo; Christopher Ritchlin; Jose U Scher; Roopesh Singh; Nicole L Ward; Stacie Bell; Wilson Liao
Journal:  J Invest Dermatol       Date:  2021-07-22       Impact factor: 8.551

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.